Edition:
United Kingdom

Ucb SA (UCB.BR)

UCB.BR on Brussels Stock Exchange

76.76EUR
14 Nov 2018
Change (% chg)

-- (--)
Prev Close
€76.76
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
350,880
52-wk High
€81.48
52-wk Low
€60.08

Chart for

About

Ucb SA is a Belgium-based biopharmaceutical and specialty chemical company that specializes in two therapeutic areas: diseases of the central nervous system (CNS) and immunology. In the area of central nervous system disorders, the Company is focused on epilepsy, diabetic neuropathic pain, multiple sclerosis, fibromyalgia,... (more)

Overall

Beta: 0.92
Market Cap(Mil.): €11,689.79
Shares Outstanding(Mil.): 194.51
Dividend: 1.15
Yield (%): 1.34

Financials

  UCB.BR Industry Sector
P/E (TTM): 17.05 30.86 33.64
EPS (TTM): 3.53 -- --
ROI: 8.89 14.72 14.22
ROE: 12.31 16.27 15.99

CORRECTED-BRIEF-UCB's Midazolam Nasal Spray Granted Orphan Drug Designation

* FDA ACCEPTS NEW DRUG APPLICATION (NDA) TO REVIEW MIDAZOLAM NASAL SPRAY

13 Aug 2018

Earnings vs. Estimates